Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy and Safety of AK101 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT05120297 is registered in ClinicalTrials.gov with Akeso as lead sponsor.

NCT NCT05120297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy and Safety of AK101 in Subjects With Moderate-to-severe Plaque Psoriasis
Lead sponsor
Akeso
Phase
Phase 3
Overall status
Completed
Start date
November 29, 2021
Completion date
September 29, 2022
Enrollment
452 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis vulgaris